(Q42426113)

31 October 2017

The influence of drugs upon the anticoagulant activity of heparin (English)

1 reference

31 October 2017

1 reference

Hodby ED

1

1 reference

31 October 2017

Hirsh J

series ordinal

2

1 reference

31 October 2017

Adeniyi-Jones C

series ordinal

3

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 March 1972

1 reference

Canadian Medical Association Journal

31 October 2017

1 reference

31 October 2017

106

1 reference

31 October 2017

5

1 reference

31 October 2017

562-564

1 reference

The Activated Partial Thromboplastin Time in the Control of Heparin Treatment

31 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1940461

Treatment of pulmonary embolic disease. A critical review of some aspects of current therapy

28 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1940461

Heparin: molecular weight and degradation studies

28 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1940461

Extemporaneous sterile compounding of intravenous additives

28 May 2018

1 reference

12 December 2020

Heparin Metabolism: Isolation and Characterization of Uroheparin

1 reference

12 December 2020

Some incompatibilities of intravenous admixtures

1 reference

12 December 2020

Current concepts: the use of heparin

1 reference

12 December 2020

Problems with Intravenous Additives

1 reference

12 December 2020

STABILITY OF HEPARIN SOLUTIONS

1 reference

12 December 2020

Identifiers

1 reference

31 October 2017

1 reference